MedTrace Logo

Addressing Barriers to Adult Hearing Healthcare

NCT02928107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1146

Last updated 2021-11-09

No results posted yet for this study

Summary

The aim of this project is to develop evidence that can inform hearing health care best practices for adults between the ages of 65-75, and determine what level of involvement by the primary care practitioner (PCP) is required to inform and encourage adults age 65-75 to follow through with routine hearing screening.

This study also aims to evaluate the accuracy of assessment of medical conditions for which the FDA requires physician evaluation and management prior to hearing aid fitting, and determine which medical conditions should require medical evaluation prior to hearing aid fitting.

The results of this study should provide information to implement changes in health care policy to facilitate accessible and affordable hearing health care.

Conditions

Interventions

OTHER

Tele-HS

Patients will be given information on the Tele-HS and given access to take the screening at home or in-office, depending on arm.

OTHER

PCP encouragement

Patients will or will not either receive PCP encouragement to do the Tele-HS.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • Sherri Smith, PhD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2021-08-27
Completion
2021-08-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928107 on ClinicalTrials.gov